6FFG
Human BRD2 C-terminal bromodomain with (S)-1-(2-cyclopropyl-4-(2-(hydroxymethyl)benzyl)-6-(1,2,3,6-tetrahydropyridin-4-yl)-3,4-dihydroquinoxalin-1(2H)-yl)ethanone
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E SUPERBRIGHT |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-10-25 |
Detector | RIGAKU SATURN A200 |
Wavelength(s) | 1.54178 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 71.599, 52.842, 32.105 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 21.780 - 1.590 |
R-factor | 0.17197 |
Rwork | 0.170 |
R-free | 0.20537 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.004 |
RMSD bond angle | 1.066 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Refinement software | REFMAC (5.8.0073) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 71.600 | 1.680 |
High resolution limit [Å] | 1.590 | 1.590 |
Rmerge | 0.025 | 0.149 |
Number of reflections | 16469 | 2096 |
<I/σ(I)> | 27.3 | 5.4 |
Completeness [%] | 97.6 | 87.6 |
Redundancy | 2.9 | 1.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 6.5 | 293 | 0.1M MES, pH6.5 30% PEG300 |